Li Kang Biomedical Co - Stock

Li Kang Biomedical Co ROCE 2024

Li Kang Biomedical Co ROCE

0.21

Ticker

6242.TWO

ISIN

TW0006242001

In 2024, Li Kang Biomedical Co's return on capital employed (ROCE) was 0.21, a -12.13% increase from the 0.24 ROCE in the previous year.

Li Kang Biomedical Co Aktienanalyse

What does Li Kang Biomedical Co do?

Li Kang Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Li Kang Biomedical Co's Return on Capital Employed (ROCE)

Li Kang Biomedical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Li Kang Biomedical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Li Kang Biomedical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Li Kang Biomedical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Li Kang Biomedical Co Stock

What is the ROCE (Return on Capital Employed) of Li Kang Biomedical Co this year?

The ROCE of Li Kang Biomedical Co is 0.21 undefined this year.

How has the ROCE (Return on Capital Employed) of Li Kang Biomedical Co developed compared to the previous year?

The ROCE of Li Kang Biomedical Co has increased by -12.13% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Li Kang Biomedical Co?

A high Return on Capital Employed (ROCE) indicates that Li Kang Biomedical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Li Kang Biomedical Co?

A low ROCE (Return on Capital Employed) can indicate that Li Kang Biomedical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Li Kang Biomedical Co impact the company?

An increase in the ROCE of Li Kang Biomedical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Li Kang Biomedical Co affect the company?

A decrease in ROCE of Li Kang Biomedical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Li Kang Biomedical Co?

Some factors that can affect Li Kang Biomedical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Li Kang Biomedical Co so important for investors?

The ROCE of Li Kang Biomedical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Li Kang Biomedical Co take to improve the ROCE?

To improve the ROCE, Li Kang Biomedical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Li Kang Biomedical Co pay?

Over the past 12 months, Li Kang Biomedical Co paid a dividend of 1.74 TWD . This corresponds to a dividend yield of about 3.46 %. For the coming 12 months, Li Kang Biomedical Co is expected to pay a dividend of 1.74 TWD.

What is the dividend yield of Li Kang Biomedical Co?

The current dividend yield of Li Kang Biomedical Co is 3.46 %.

When does Li Kang Biomedical Co pay dividends?

Li Kang Biomedical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Li Kang Biomedical Co?

Li Kang Biomedical Co paid dividends every year for the past 2 years.

What is the dividend of Li Kang Biomedical Co?

For the upcoming 12 months, dividends amounting to 1.74 TWD are expected. This corresponds to a dividend yield of 3.46 %.

In which sector is Li Kang Biomedical Co located?

Li Kang Biomedical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Li Kang Biomedical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Li Kang Biomedical Co from 7/26/2024 amounting to 2.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.

When did Li Kang Biomedical Co pay the last dividend?

The last dividend was paid out on 7/26/2024.

What was the dividend of Li Kang Biomedical Co in the year 2023?

In the year 2023, Li Kang Biomedical Co distributed 1.242 TWD as dividends.

In which currency does Li Kang Biomedical Co pay out the dividend?

The dividends of Li Kang Biomedical Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Li Kang Biomedical Co

Our stock analysis for Li Kang Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Li Kang Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.